Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 4 1

Status

Recruiting 2Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 1Head & Neck 1

Conditions

Patients Who Are Treated With Tyrosine Kinase Inhibitors 1Neoplasms 1Head and Neck Neoplasms 1

Interventions

Cyclophosphamide 2042Radiotherapy 1859Cisplatin 1825Carboplatin 1533Gemcitabine 1434Paclitaxel 1289Bevacizumab 1270Docetaxel 1202pembrolizumab 1199Oxaliplatin 1160Capecitabine 1144Fluorouracil 1061Dexamethasone 971Rituximab 919Nivolumab 908Magnetic Resonance Spectroscopy 862Etoposide 839Doxorubicin 823Drug Therapy 792Radiosurgery 776Irinotecan 775Cytarabine 736fludarabine 716Leucovorin 676Lenalidomide 608fludarabine phosphate 564Temozolomide 552Radiation 541Filgrastim 540Cetuximab 537

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Interventional × Taste × Clear all
NCT07258589 2025-12-02

TASTY-training

University Medical Center Groningen

Phase NA Recruiting
90 enrolled

Patients Who Are Treated With Tyrosine Kinase Inhibitors

NCT07041710 2025-06-27

AGORA

Médipôle Lyon-Villeurbanne

Phase NA Recruiting
104 enrolled
Tumor-Agnostic

Neoplasms

NCT05046028 2023-03-24

Individualization of Nutritive Sensory Support Of Radiation Therapy

National Medical Research Radiological Centre of the Ministry of Health of Russia

Phase 4 Completed
100 enrolled
Head & Neck

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡